Newbridge Financial Services Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$134K Sell
2,803
-1,924
-41% -$82.7K 0.02% 296
2026
Q1
$174K Buy
4,727
+2,625
+125% +$124K 0.03% 234
2025
Q4
$107K Hold
2,102
0.02% 311
2025
Q3
$117K Buy
2,102
+1,845
+718% +$108K 0.02% 369
2025
Q2
$17.7K Buy
257
+10
+4% +$680 ﹤0.01% 751
2025
Q1
$17.2K Sell
247
-301
-55% -$24.9K ﹤0.01% 577
2024
Q4
$47.1K Sell
548
-19,642
-97% -$2.12M 0.01% 419
2024
Q3
$2.4M Buy
20,190
+3,242
+19% +$432K 0.84% 30
2024
Q2
$2.42M Buy
16,948
+4,233
+33% +$561K 0.9% 22
2024
Q1
$1.63M Buy
12,715
+8,325
+190% +$991K 0.71% 24
2023
Q4
$454K Buy
4,390
+3,903
+801% +$386K 0.22% 104
2023
Q3
$44.3K Sell
487
-89
-15% -$7.84K 0.02% 434
2023
Q2
$46.6K Buy
576
+288
+100% +$23.5K 0.02% 476
2023
Q1
$22.9K Hold
288
0.01% 666
2022
Q4
$19.5K Hold
288
0.01% 725
2022
Q3
$14K Hold
288
0.01% 796
2022
Q2
$16K Hold
288
0.01% 725
2022
Q1
$16K Buy
288
+200
+227% +$10.3K 0.01% 789
2021
Q4
$5K Hold
88
﹤0.01% 1077
2021
Q3
$4K Buy
88
+2
+2% +$97 ﹤0.01% 1068
2021
Q2
$4K Hold
86
﹤0.01% 1173
2021
Q1
$3K Buy
+86
New +$3.06K ﹤0.01% 1128

Other funds holding NVO

Newbridge Financial Services Group's NVO Position: Q2 2026 in Review

Newbridge Financial Services Group reduced its Novo Nordisk (NVO) stake by 41% in Q2 2026, selling an estimated $82.7K and leaving 2,803 shares worth $134K. The position accounts for 0.02% of the portfolio, ranked #296.

Newbridge Financial Services Group first reported a position in NVO in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.42M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Newbridge Financial Services Group held 2,803 shares of Novo Nordisk worth $134K as of Q2 2026.
  • Newbridge Financial Services Group sold 1,924 Novo Nordisk shares in Q2 2026, an estimated $82.7K.
  • Novo Nordisk made up 0.02% of Newbridge Financial Services Group's portfolio in Q2 2026, its #296 holding.
  • Newbridge Financial Services Group first reported a position in Novo Nordisk in Q1 2021 and has held it in 22 quarters since.
  • Newbridge Financial Services Group's Novo Nordisk position peaked at $2.42M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.